Fujian Sbs Zipper Scienceand Technology Co.Ltd(002098) : independent opinions of independent directors on matters related to the first meeting of the seventh board of directors

Fujian Sbs Zipper Scienceand Technology Co.Ltd(002098) independent director

Independent opinions on matters related to the first meeting of the seventh board of directors

In accordance with relevant laws, regulations and normative documents such as the rules for independent directors of listed companies, the stock listing rules of Shenzhen Stock Exchange, the self regulatory guidelines for listed companies of Shenzhen Stock Exchange No. 1 – standardized operation of listed companies on the main board and the relevant provisions of the articles of association of Fujian Sbs Zipper Scienceand Technology Co.Ltd(002098) , we are the independent directors of Fujian Sbs Zipper Scienceand Technology Co.Ltd(002098) (hereinafter referred to as the company), Deliberated on the relevant proposals of the first meeting of the seventh board of directors of the company, and expressed the following independent opinions:

Independent opinions on the appointment of senior managers

1. The nomination and appointment procedures of the company’s senior managers comply with relevant laws, regulations and normative documents such as the company law of the people’s Republic of China, the stock listing rules of Shenzhen Stock Exchange, the self regulatory guidelines for listed companies of Shenzhen Stock Exchange No. 1 – standardized operation of listed companies on the main board, as well as the relevant provisions of the Fujian Sbs Zipper Scienceand Technology Co.Ltd(002098) articles of association, The procedure is legal and valid.

2. After reviewing the resume materials of relevant personnel, the senior managers of the company appointed this time have met the employment conditions specified in relevant laws, administrative regulations, departmental rules, normative documents and the articles of association, and there is no case that they are determined as market banned by China Securities Regulatory Commission and the ban has not been lifted, Nor has it been subject to any punishment or punishment from the China Securities Regulatory Commission and Shenzhen Stock Exchange, nor has it been filed for investigation by judicial organs for suspected crimes or by the China Securities Regulatory Commission for suspected violations of laws and regulations; Nor does it belong to the “dishonest executee”.

3. After understanding the educational background and work experience of relevant personnel, we believe that the senior managers appointed this time have the professional ethics, professional knowledge and management ability required to perform their corresponding duties and are competent for the corresponding posts.

4. The number of senior managers appointed this time will not exceed one-half of the total number of directors of the company.

5. Ms. Xie Jingbo has obtained the qualification certificate of secretary of the board of directors issued by Shenzhen Stock Exchange and has the necessary professional knowledge and ability to perform the duties of secretary of the board of directors.

To sum up, we agree that the company will continue to employ Mr. Shi Mingqu as the president of the company; Renew the appointment of Mr. Shi xiongmeng as the CEO of the company; Renew the appointment of Mr. Zhang Jianqun as vice president and financial director of the company; Renew Ms. Xie Jingbo as vice president and Secretary of the board of directors of the company. The term of office of the above-mentioned senior managers starts from the date of deliberation and approval of the current board of directors to the date of expiration of the term of office of the seventh board of directors of the company.

(no text on the next page)

(there is no text on this page, which is the signature and seal page of Fujian Sbs Zipper Scienceand Technology Co.Ltd(002098) independent directors’ independent opinions on matters related to the first meeting of the seventh board of directors) independent directors:

Lin Junguo, Zhang Zhong

January 27, 2022

- Advertisment -